Levonorgestrel
(Synonyms: 左炔诺孕酮; D-Norgestrel) 目录号 : GC14704
Levonorgestrel是一种口服有效的孕酮抑制剂。
Cas No.:797-63-7
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Levonorgestrel is an effective oral progesterone inhibitor [1]. Levonorgestrel can be used for contraception and can be combined with other drugs. Levonorgestrel has anti-cancer activity and can induce cell apoptosis, and is used in the research of osteoporosis and uterine leiomyoma [2].
In vitro, Levonorgestrel (5-25μg/mL; 72h) can inhibit cell proliferation and promote cell apoptosis in uterine smooth muscle tumor cells in a concentration-dependent manner. It can significantly reduce the expression of Bcl-2 and Survivin, increase the phosphorylation level of p38, and activate caspase 3 [2]. Levonorgestrel (50μM) has a time-dependent inhibitory effect on the proliferation of HESCs and HEGCs, and significantly increases cell apoptosis. Levonorgestrel causes a time-dependent increase in the total Cx43 content, but does not cause changes in Ser368 phosphorylated Cx43, while Ser255 phosphorylated Cx43 shows a nuclear translocation phenomenon [3].
In vivo, after random mating in mice, Levonorgestrel (8mg/kg) isintraperitoneally injected immediately, and the frequency of ciliary beating of the fallopian tubes (CBF) in mice decreases significantly. The average percentage of embryo-tube retention in the Levonorgestrel group is 18.27% [4]. Oral administration of Levonorgestrel (0.67mg/kg/day) and quinestrol for 7 days significantly reduces sperm count in SD rats and decreases androgen receptor and Wilms tumor nuclear protein 1 (WT1) staining. Quinestrolalone or in combination with Levonorgestrel induces low fertility in male rats, primarily by interfering with reproductive cell differentiation [5].
References:
[1] Tellería CM, Carrizo DG, Deis RP. Levonorgestrel inhibits luteinizing hormone-stimulated progesterone production in rat luteal cells. J Steroid Biochem Mol Biol. 1994 Aug;50(3-4):161-6.
[2] Xu Qing, et al. Levonorgestrel inhibits proliferation and induces apoptosis in uterine leiomyoma cells. Contraception vol. 82,3 (2010): 301-8.
[3] Zhao X, Tang X, Ma T, et al. Levonorgestrel inhibits human endometrial cell proliferation through the upregulation of gap junctional intercellular communication via the nuclear translocation of Ser255 phosphorylated Cx43[J]. BioMed Research International, 2015, 2015(1): 758684.
[4] Li C, Zhang H Y, Liang Y, et al. Effects of Levonorgestrel and progesterone on Oviductal physiology in mammals[J]. Reproductive Biology and Endocrinology, 2018, 16(1): 59.
[5] Liu M, Wan X, Yin Y, et al. Subfertile effects of quinestrol and levonorgestrel in male rats[J]. Reproduction, Fertility and Development, 2012, 24(2): 297-308.
Levonorgestrel是一种口服有效的孕酮抑制剂 [1]。Levonorgestrel能够用于避孕且能与其他药物进行联用。Levonorgestrel具有抗癌活性，能够诱导细胞凋亡，能够用于骨质疏松、子宫平滑肌瘤的研究 [2]。
在体外，Levonorgestrel (5-25μg/mL; 72h) 在子宫平滑肌瘤细胞中能以浓度依赖方式抑制细胞增殖和促进细胞凋亡，能够显著降低Bcl-2和Survivin的表达，升高p38磷酸化水平以及激活caspase 3 [2]。Levonorgestrel（50μM）对HESCs和HEGCs的增殖有时间依赖性的抑制作用，并显著增加细胞凋亡。Levonorgestrel以时间依赖的方式导致总Cx43的含量相对增加，但并未引起Ser368磷酸化Cx43的变化，而Ser255磷酸化Cx43出现了核内转移的现象 [3]。
在体内，在小鼠进行随机交配后立即腹腔注射Levonorgestrel（8mg/kg），小鼠体内输卵管纤毛搏动频率（CBF）显著降低。Levonorgestrel组小鼠的平均胚胎-输卵管保留百分比为18.27% [4]。Levonorgestrel（0.67mg/kg/day）和quinestrol通过口服给药7天，显著减少了SD大鼠的精子数量，并且雄激素受体和Wilms肿瘤核蛋白1染色减少。quinestrol单独或与Levonorgestrel组合诱导雄性大鼠生育力低下，主要是通过干扰生殖细胞分化 [5]。
| Cell experiment [1]: | |
Cell lines | Human endometrial stromal cells (HESCs) and glandular cells (HEGCs) |
Preparation Method | HESCs and HEGCs were placed in 200 μl of culture media per well in a 96-well plate with a density of 2 × 104 cells/mL and incubated overnight to allow the cells to attach to the wells. The cells were then treated with 2 μL of Levonorgestrel in a concentration course manner (1×10−3, 10, 25, or 50μM) and in a time course (24h, 48h, and 72h), with Estradiol (E2) as the opposite control, and DMSO (0.5%) as the negative control. The concentration of Levonorgestrel displaying an inhibitory effect and that of E2 exhibiting a stimulatory effect on cell proliferation (both were 50μM) were adopted as the final treating concentrations during the followed experiments determined according to the preliminary experiments. The concentration of 50μM Levonorgestrel is similar to that in the vivo endometrium in the presence of a mirena with a releasing rate of 20 μg/24 hours of Levonorgestrel. Subsequently, the MTT method was used for detection. |
Reaction Conditions | 1×10−3, 10, 25, or 50μM ; 24h, 48h and 72h |
Applications | 50μM Levonorgestrel inhibited the cell proliferation of primary HESCs significantly over time (24h, 48h, and 72h). |
| Animal experiment [2]: | |
Animal models | C57BL/6 |
Preparation Method | Eight-week-old C57BL/6 J mice were used in this study (Shanghai Research Center for Model Organisms). All animal experiments were approved by the Medical Ethics Committee of Shanghai Research Center for Model Organisms. The mice were housed in a room at 25°C with a 12-h light:12-hdark cycle and 50–60% humidity and were given a standard diet (containing 10% fat) and water. Female mice (6–8 weeks of age) were mated randomly, and vaginal plug-positive mice were immediately injected intraperitoneally with saline, Levonorgestrel (8mg/kg), or Progesterone (8mg/kg). Twelve hours after observation of the vaginal plug, the mice were sacrificed via cervical dislocation to measure the CBF. Embryo-tube transportation assays were conducted as described by Ning et al. Seventy-four hours after observation of the vaginal plug, the oviducts and uterus were ligated. The embryos were flushed from the oviducts or uteri with PBS. We counted the embryos remaining in the oviducts, and the results are expressed as percentages of the total number of embryos. |
Dosage form | 8mg/kg once; i.p. |
Applications | All the mice in the Levonorgestrel group experienced embryo-tube retention, with an average percentage of embryo retention of 18.27%, whereas none of the mice in the saline-treated group experienced embryo-tube retention. Consistently, the same effect was also observed in the Progesterone group, which had an average percentage of embryo retention of 15.37%, compared with the control group, which had an average percentage of 0%. |
References: | |
| Cas No. | 797-63-7 | SDF | |
| 别名 | 左炔诺孕酮; D-Norgestrel | ||
| 化学名 | (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | ||
| Canonical SMILES | CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34 | ||
| 分子式 | C21H28O2 | 分子量 | 312.45 |
| 溶解度 | ≥ 13.8mg/mL in DMSO | 储存条件 | Store at 2-8°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.2005 mL | 16.0026 mL | 32.0051 mL |
| 5 mM | 0.6401 mL | 3.2005 mL | 6.401 mL |
| 10 mM | 0.3201 mL | 1.6003 mL | 3.2005 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet